Correlation Between Royal Bank and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Royal Bank and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Bank and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royal Bank of and Pfizer Inc CDR, you can compare the effects of market volatilities on Royal Bank and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Bank with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Bank and Pfizer.

Diversification Opportunities for Royal Bank and Pfizer

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Royal and Pfizer is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Royal Bank of and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Royal Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Bank of are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Royal Bank i.e., Royal Bank and Pfizer go up and down completely randomly.

Pair Corralation between Royal Bank and Pfizer

Assuming the 90 days horizon Royal Bank of is expected to generate 0.56 times more return on investment than Pfizer. However, Royal Bank of is 1.78 times less risky than Pfizer. It trades about 0.19 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.02 per unit of risk. If you would invest  14,568  in Royal Bank of on August 28, 2024 and sell it today you would earn a total of  2,809  from holding Royal Bank of or generate 19.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Royal Bank of  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Royal Bank 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Royal Bank of are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Royal Bank may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Royal Bank and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Royal Bank and Pfizer

The main advantage of trading using opposite Royal Bank and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Bank position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Royal Bank of and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum